Clinical trials

  • AMIVANTAMAB for Non-small cell lung cancer (EGFR-mutated), advanced or metastatic
  • REPOTRECTINIB for Non-small cell lung cancer
  • FILGOTINIB for Juvenile idiopathic arthritis
  • risdiplam for Spinal muscular atrophy
  • TRASTUZUMAB DERUXTECAN for HER2-expressing or HER2-mutated advanced (unresectable or metastatic) solid tumors
  • TOZORAKIMAB for Chronic obstructive pulmonary disease
  • Radium Ra 223 dichloride for Metastatic castration-resistant prostate cancer
  • Ceftazidime; Avibactam for Bacterial infection in critically ill patients undergoing continuous renal replacement therapy
  • CEFTRIAXONE SODIUM for Threatened late miscarriage | Threatened abortion antepartum
  • SPARSENTAN for Proteinuric glomerular diseases|Focal segmental glomerulosclerosis|Minimal change disease|IgA nephropathy|IgA vasculitis|Alport syndrome
  • nitrous oxide, oxygen for Suicidal ideation
  • ACP-204 TARTRATE for Dementia with Lewy bodies|Lewy body Dementia psychosis (LBDP)